With Europe’s population living longer, the quest for new Alzheimer’s disease (AD) therapies has never been more urgent. Researchers hope that figuring out which genes and environmental factors trigger the illness will deliver drugs that prevent serious memory loss.
Researchers are mapping brain circuits and testing an approved drug to inhibit strong fear memories.
Hurdles include cost and fears over fires.
Dr Kate Rychert studies ocean plate structures.